VAERS Explorer
Back to explore

Report #2845360

Received Jun 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
IN
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
YFYELLOW FEVER (YF-VAX)SANOFI PASTEURUNKUK137AAOT

Symptoms (2)

No adverse eventProduct preparation error

Symptom narrative

administered a YF-Vax reconstituted using sterile water with no reported adverse event; Initial information received on 13-Jun-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age female patient who was administered a yellow fever vaccine -[YF-VAX] reconstituted using sterile water with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect yellow fever vaccine - reconstituted using sterile water (formulation: Solution for injection) (lot UK137AA and expiry date 31-Jan-2026) (strength not reported) via unknown route in unknown administration site for immunization with no reported adverse event (product preparation error) (Latency: same day). Reportedly, she was administered yellow fever vaccine and noticed there was two vials of the sodium chloride left which should have been used with the vaccine. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.